Contract Development of Lyophilised Orally Disintegrating Tablets

Contract Development of Lyophilised Orally Disintegrating Tablets
Product Description

InstaPill®’s advanced technology platform enables the development of orally disintegrating tablets that eliminate the need for water offering a smoother administration experience for patients who struggle with swallowing including children, older adults and individuals with psychiatric or neurological conditions.

Read more Show less

InstaPill Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Biopharmaceutical
Contract Manufacturer
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
View company profile
Categories
more categories Show less
Specifications
  • Details
    Quick dissolve tablets formed using a high-precision linear peristaltic pump ensures dose uniformity.
  • Selling Points
    InstaPill® delivers a competitive edge through a differentiated delivery format that improves adherence and enables faster market entry. Whether expanding an existing portfolio or exploring new therapeutic segments, our solutions are built to align with regulatory expectations and long-term commercial success.
  • Model
    Contract Development of Lyophilised Orally Disintegrating Tablets
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

InstaPill Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2025
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Biopharmaceutical
Contract Manufacturer
OTC
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Technology
View company profile

More Products from InstaPill Private Limited (2)

InstaPill Private Limited resources (3)